Adlai Nortye Ltd. American Depositary Shares (ANL) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $782.93M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Biotechnology |
| Country | KY | CEO | Yang Lu |
| IPO Date | 2023-09-29 | CAGR | — |
| Employees | 109 | Website | www.adlainortye.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $99.51M | P/E | -10.61 | Forward P/E | -53.44 | PEG | — |
| P/S | 31.83 | P/B | 0.87 | P/CF | -3.23 | P/FCF | -10.76 |
| Sales | $19.68M | Sales 1Y | 203.24% | Sales 3Y | — | Sales 5Y | — |
| EPS | $-1.39 | EPS 1Y | -72.32% | EPS 3Y | — | EPS 5Y | — |
| Sales QoQ | — | EPS QoQ | — | Sales QoQ Avg | 107.29% | EPS QoQ Avg | -32.02% |
| Gross Margin | 100% | Operating Margin | -113.28% | Profit Margin | -114.48% | ROCE | -9.99% |
| ROA | -9% | ROE | -22% | Altman Z Score | 12.02 | Piotroski Score | 2 |
| Current Ratio | 9.55 | Quick Ratio | 9.55 | Cash Ratio | 5.26 | Op. CF Ratio | -0.3 |
| Debt/Equity | 0.12 | Debt/Assets | 0.11 | Lt Debt/Equity | 0.04 | Lt Debt/Cap. | 0.03 |
| Intrst Cov. | — | Inventory Turnover | — | Asset Turnover | 0.08 | Receivables Turnover | 74.55 |
| Enterprise Value | $99.51M | P/E Ratio | -10.61 |
| Forward P/E | -53.44 | PEG Ratio | — |
| P/S Ratio | 31.83 | P/B Ratio | 0.87 |
| P/CF Ratio | -3.23 | P/FCF Ratio | -10.76 |
| EPS | $-1.39 | EPS Growth 1Y | -72.32% |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 203.24% | Gross Margin | 1% |
| Operating Margin | -1.13% | Profit Margin | -1.14% |
| ROE | -0.22% | ROA | -0.09% |
| ROCE | -0.1% | Current Ratio | 9.55 |
| Quick Ratio | 9.55 | Cash Ratio | 5.26 |
| Debt/Equity | 0.12 | Interest Coverage | — |
| Altman Z Score | 12.02 | Piotroski Score | 2 |
View Adlai Nortye Ltd. American Depositary Shares financial charts →
Adlai Nortye Ltd. American Depositary Shares (ANL) valuation & financials
Adlai Nortye Ltd. American Depositary Shares (ANL) has a market capitalization of $782.93M and trades at a price-to-earnings ratio of -10.6. It operates in the Healthcare sector (Biotechnology).
Adlai Nortye Ltd. American Depositary Shares's revenue grew +203.2% over the last year.
Adlai Nortye Ltd. American Depositary Shares's next earnings report is scheduled for March 3, 2027; analysts estimate EPS of $-0.13. Check the earnings calendar to see all companies reporting this week.
Adlai Nortye Ltd. American Depositary Shares (ANL) — frequently asked questions
When does Adlai Nortye Ltd. American Depositary Shares (ANL) report earnings next?
Adlai Nortye Ltd. American Depositary Shares is expected to report earnings on March 3, 2027. Analysts estimate EPS of $-0.13.
What is Adlai Nortye Ltd. American Depositary Shares's market cap?
Adlai Nortye Ltd. American Depositary Shares (ANL) has a market capitalization of $782.93M.
What is ANL's P/E ratio?
Adlai Nortye Ltd. American Depositary Shares trades at a price-to-earnings ratio of -10.6, with trailing twelve-month EPS of $-1.39.
How fast is Adlai Nortye Ltd. American Depositary Shares growing?
Adlai Nortye Ltd. American Depositary Shares's revenue grew +203.2% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)
Adlai Nortye Ltd. American Depositary Shares revenue & earnings charts →